 |
4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl |
|---|---|
| Trade Name | |
| Orphan Indication | Cerebral cavernous malformation |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-29 00:00:00 |
| Sponsor | Recursion Pharmaceuticals, LLC;383 S. Colorow Drive;Salt Lake City, Utah, 84108 |
